NCT03603210View on ClinicalTrials.gov

Outcomes of Drug Coated Balloon Angioplasty, A UK Real Life Experience From 2009 to 2015

Active, not recruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

September 11, 2017

Primary Completion Date

January 31, 2027

Study Completion Date

January 31, 2027

Conditions
Ischaemic Heart Disease
Interventions
DEVICE

Drug coated balloon angioplasty

Drug coated balloons are semi compliant percutaneous coronary angioplasty balloons coated with a chemotherapeutic drug such as Paclitaxel used with an excipient which allows rapid absorption to vessel wall upon balloon expansion for 30-60s. This allows coronary angioplasty without any permanent or semi- permanent stent or scaffold provided there are no vessel threatening dissections or significant acute recoil.

Trial Locations (1)

NR4 7UY

Norfolk and Norwich University Hospital, Norwich

All Listed Sponsors
lead

Julie Dawson

OTHER

NCT03603210 - Outcomes of Drug Coated Balloon Angioplasty, A UK Real Life Experience From 2009 to 2015 | Biotech Hunter | Biotech Hunter